Ketamine Use in Child and Adolescent Psychiatry: Emerging Data in Treatment-Resistant Depression, Insights from Adults, and Future Directions

AbstractPurpose of ReviewThe following review will explore ketamine ’s antidepressant and antisuicidal properties in adults, review of what is known about ketamine’s safety in children, and summarize the limited information we have on ketamine’s role in treating depression and suicidal ideation in adolescents with depression. Future directions for ketamine’s role in child psychiatry based on animal and adult studies will also be explored.Recent FindingsOver the past 20  years, ketamine has emerged as a novel treatment for depression and suicidal ideation in adults. In recent years, these studies have been extended to adolescents. In 2021, the first placebo-controlled trial examining ketamine’s antidepressant potential in adolescents was performed, demonstrating superior efficacy over midazolam.SummaryInitial studies suggest that ketamine functions as a rapidly acting antidepressant in adolescents. Case reports suggest that ketamine may also reduce suicidal ideation in this population. However, existing studies are small, and more research is needed to solidify these findings and inform clinical practice.
Source: Current Psychiatry Reports - Category: Psychiatry Source Type: research